Global Healthcare Corporate M&A 2018

Global corporate M&A activity in healthcare surged in 2017, fueled by relentless pressure on companies to contain costs and boost returns. Total deal value rose 27%, to $332 billion, while deal count increased 16%, to 3,099. Three megamergers (that is, deals valued at greater than $20 billion), with a collective value of $126 billion, accounted for more than one-third of the total. Want to know more?


Recent Posts

See All

AbbotT, EUA, COVID-19 antigen test

Abbott gets EUA; COVID-19 antigen test #covid19test#antigen#covid19 Already in the antigen game - BD / Quidel / LumiraDx Abbott`s USP = scale + price scale - Abbott: 50 M / month by October - BD: 8 M

  • LinkedIn Social Icon

© 2019 IntMeDA